Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer

Name: Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer
License: Public Domain

M.D. Anderson Cancer Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

braf np_004324.2:p.v600e, metastatic colon adenocarcinoma, metastatic microsatellite stable colorectal carcinoma, metastatic rectal adenocarcinoma, progressive disease, recurrent colorectal carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 411393
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.